Related Experiment Video
Updated: Feb 22, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Splitting FND: Differences in targeted therapies for functional movement disorders and functional seizures
1Brand University of Applied Sciences Hamburg, Lilienstraße 5-9, Hamburg, 20095, Germany; Technical University Berlin, Hardenbergstraße 16-18, Berlin, 10623, Germany.
None:
This article examines how functional neurological disorder (FND), historically called hysteria, is currently enacted in biomedical treatment discourse. Drawing on Annemarie Mol's concept of enactment, it explores how different therapeutic approaches produce divergent versions of the disorder across symptom clusters. Through a close reading of eleven narrative reviews published between 2016 and 2025, I analyse how targeted therapies for functional motor symptoms and functional seizures are justified, how they relate to diagnostic logic, and how they are shaped by historical assumptions. While both symptom clusters are diagnosed through rule-in criteria based on physical signs-rather than psychological aetiology-their treatment diverges substantially. Functional motor symptoms are increasingly addressed through FND-specific physiotherapy, grounded in neuroimaging studies and aimed at retraining automatic movement. Functional seizures, by contrast, are treated through adapted psychological therapies, particularly CBT-based interventions targeting emotion, stress, and behaviour. This divergence, I argue, enacts a therapeutic split that implicitly reflects a historical mind-body dualism. The disorder is neurologically diagnosed in both cases, yet treated physically in only one. Rarely problematised in the literature, this discrepancy has consequences for patients and FND's coherence as a diagnosis. This finding highlights a structural inconsistency in current clinical reasoning and raises questions about how FND might be managed without perpetuating outdated assumptions about emotion and the nature of somatic symptoms.
More Related Videos
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...